Evidence map›Paper›PMID 38900911›Full record

ArticleScience (New York, N.Y.)2024

Structure and repair of replication-coupled DNA breaks.

Raphael Pavani, Veenu Tripathi, Kyle B Vrtis, Dali Zong, Raj Chari, Elsa Callen, Ajith V Pankajam, Gang Zhen, Gabriel Matos-Rodrigues, Jiajie Yang and 6 more

Abstract read
In one paragraph

Article in Science (New York, N.Y.), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 74 papers.

0numbers the graph read from it
0cells of the map it votes in
74citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

74 citing papers in PubMed.

  1. Review
  2. Review
  3. Mechanisms and disease relevance of DNA break repair pathway choice.Nature reviews. Molecular cell biology · 2026
    Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review

14 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Raphael Pavani *Laboratory of Genome Integrity, National Cancer Institute, NIH, Bethesda, MD, USA.ORCID 0000-0002-7187-2995
Veenu Tripathi *Laboratory of Genome Integrity, National Cancer Institute, NIH, Bethesda, MD, USA.
Kyle B VrtisDepartment of Biological Chemistry and Molecular Pharmacology, Blavatnik Institute, Harvard Medical School, Boston, MA, USA.ORCID 0000-0002-9851-0396
Dali ZongLaboratory of Genome Integrity, National Cancer Institute, NIH, Bethesda, MD, USA.ORCID 0000-0001-6019-2970
Raj ChariGenome Modification Core, Frederick National Lab for Cancer Research, Frederick, MD, USA.ORCID 0000-0002-2216-313X
Elsa CallenLaboratory of Genome Integrity, National Cancer Institute, NIH, Bethesda, MD, USA.
Ajith V PankajamLaboratory of Genome Integrity, National Cancer Institute, NIH, Bethesda, MD, USA.
Gang ZhenLaboratory of Genome Integrity, National Cancer Institute, NIH, Bethesda, MD, USA.
Gabriel Matos-RodriguesLaboratory of Genome Integrity, National Cancer Institute, NIH, Bethesda, MD, USA.ORCID 0000-0003-4085-7810
Jiajie YangState Key Laboratory of Molecular Biology, Shanghai Institute of Biochemistry and Cell Biology, Center for Excellence in Molecular Cell Science, Chinese Academy of Sciences, Shanghai, China.
Shuheng WuState Key Laboratory of Molecular Biology, Shanghai Institute of Biochemistry and Cell Biology, Center for Excellence in Molecular Cell Science, Chinese Academy of Sciences, Shanghai, China.
Giordano ReginatoInstitute for Research in Biomedicine, Universita della Svizzera italiana (USI), Faculty of Biomedical Sciences, Bellinzona, Switzerland.ORCID 0009-0002-5284-4339
Wei WuState Key Laboratory of Molecular Biology, Shanghai Institute of Biochemistry and Cell Biology, Center for Excellence in Molecular Cell Science, Chinese Academy of Sciences, Shanghai, China.ORCID 0000-0001-5164-2765
Petr CejkaInstitute for Research in Biomedicine, Universita della Svizzera italiana (USI), Faculty of Biomedical Sciences, Bellinzona, Switzerland.ORCID 0000-0002-9087-032X
Johannes C WalterDepartment of Biological Chemistry and Molecular Pharmacology, Blavatnik Institute, Harvard Medical School, Boston, MA, USA.ORCID 0000-0002-4186-7570
André NussenzweigLaboratory of Genome Integrity, National Cancer Institute, NIH, Bethesda, MD, USA.ORCID 0000-0002-8952-7268

Funding

DNA RepairZIABC010283 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI NUSSENZWEIG, ANDRE A. · 2009 to 2025
$27.0M
Relationship between DNA damage detection and signalingZIABC010959 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI NUSSENZWEIG, ANDRE A. · 2009 to 2025
$27.0M
The Fanconi anemia pathway: role in DNA interstrand cross-link repairR01HL098316 · NHLBI · HARVARD MEDICAL SCHOOL · PI Johannes Walter · 2010 to 2026
$6.3M
DNA REPAIRZ01BC010283 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI NUSSENZWEIG, ANDRE A. · 1998 to 2008
$2.9M
Intramural NIH HHS Z01 BC010283NCI NIH HHS HHSN261201500001GNCI NIH HHS HHSN261201500001WNCI NIH HHS HHSN261201500003INHLBI NIH HHS R01 HL098316
6 · The paper itself

Abstract

Using CRISPR-Cas9 nicking enzymes, we examined the interaction between the replication machinery and single-strand breaks, one of the most common forms of endogenous DNA damage. We show that replication fork collapse at leading-strand nicks generates resected single-ended double-strand breaks (seDSBs) that are repaired by homologous recombination (HR). If these seDSBs are not promptly repaired, arrival of adjacent forks creates double-ended DSBs (deDSBs), which could drive genomic scarring in HR-deficient cancers. deDSBs can also be generated directly when the replication fork bypasses lagging-strand nicks. Unlike deDSBs produced independently of replication, end resection at nick-induced seDSBs and deDSBs is BRCA1-independent. Nevertheless, BRCA1 antagonizes 53BP1 suppression of RAD51 filament formation. These results highlight distinctive mechanisms that maintain replication fork stability.

Indexed as

BRCA1 ProteinDNA Breaks, Double-StrandedDNA Breaks, Single-StrandedDNA ReplicationRad51 RecombinaseTumor Suppressor p53-Binding Protein 1CRISPR-Cas SystemsDNA RepairHomologous RecombinationHumansRecombinational DNA RepairBRCA1 ProteinBRCA1 protein, humanRAD51 protein, humanRad51 RecombinaseTP53BP1 protein, humanTumor Suppressor p53-Binding Protein 1

Identifiers

PMID38900911
PMCPMC11620331

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.